Rating: Cautiously Bullish | Target Price: HKD 46–51 | Current Price: HKD 44.96 (close, 2026-10-29) | Margin of Safety: +2.3% (based on base-case fair value floor of HKD 46, calculated in this report) | Time Horizon: 12 months | Confidence: 0.55
SMIC's H shares fell from HKD 68.25 (close, Sep 2) to HKD 44.96 (close, Oct 29), a decline of -34.1% (a drawdown of -36.9% from the high of HKD 71.30 on Aug 27), with no negative company announcements during the period; fundamentals actually strengthened: Q2 revenue of USD 3.006 billion (+20% QoQ, above the upper end of guidance), gross margin of 25.3%, utilization of 93.7% (as disclosed in company announcements, unverified), and Q3 gross margin guidance of 26–28%; Taiwan peers' October earnings calls confirmed mature-node price increases will extend into 2027 (Powerchip guiding for another 10–20% increase). This selloff was jointly driven by the Fed's resumption of rate hikes (+25bp on Sep 16 to 3.75–4.00%), concerns over decelerating AI capex growth (~90% in 2026 → ~36% in 2027), and sustained southbound outflows — a valuation and flow shock rather than a fundamental falsification. The current price corresponds to a PB of 1.95x (lowest in 1 year, 65th percentile over 5 years), having reverted from "richly valued" (PB 2.96x) in our previous report to the lower bound of the fair range: the probability-weighted fair value across three scenarios (bear HKD 27–36 / base HKD 46–51 / bull HKD 57–62) is approximately HKD 47.0, +4.5% versus the current price. Two core constraints cap our cautious bullishness: the MATCH equipment control bill being packaged into the Senate NDAA managers' amendment (with the Oct–Dec bicameral conference as the decisive window), and southbound outflows that have not yet stabilized. The Nov 13 Q3 results and the final NDAA text are the two events that will set the direction over the next eight weeks.
| Item | Previous | Current | Rationale for Change |
|---|---|---|---|
| Stance | neutral | Cautiously bullish | Shares fell -34% to HKD 44.96, below the base-case fair value floor of HKD 46; the previously set re-entry trigger ("reassess entry if the price falls below HKD 52 with no fundamental deterioration") has been hit, with no fundamental deterioration during the period (Q2 beat guidance, Taiwan peers confirmed 2027 price hikes) |
| Judgment | overvalued | fair | PB fell from 2.96x to 1.95x (lowest in 1 year), implying substantially compressed expectations, but reverse-engineered pricing still shows a un-cleared premium (implied steady-state ROE of 15.7–17.6% vs. actual ~5.8%) |
| Target price range | HKD 52–62 | HKD 46–51 | Overall downward shift in valuation anchor (higher risk-free rate + sector risk-off): exit multiple anchor cut from PB 2.2–2.5x to 1.9–2.1x (Hua Hong current 2.23x × 0.85–0.95, UMC 3.08x with a 30–40% discount, own 3-year median 2.25x with a 10–15% discount); FY2027 earnings path broadly unchanged |
| Confidence | 0.55 | 0.55 | Maintained: valuation divergence has narrowed, but binary policy risk (NDAA) and unresolved fund outflows limit directional conviction |
Earnings reconciliation (previous forecast vs. actual): Our previous FY2026 recurring net profit (ex-non-recurring) forecast was RMB 6.6–7.4 billion; 2026H1 actual ex-non-recurring was RMB 2.994 billion (+57.2% YoY) — normal-to-slightly-above the H1/H2 cadence implied previously. The Q3 guidance (gross margin 26–28%) supports landing in the upper half of the range, so we make a slight upward revision of FY2026 ex-non-recurring to RMB 7.0–7.8 billion; revenue forecast fine-tuned from USD 11.7–12.0 billion to USD 11.66–11.83 billion (extrapolated at the Q3 guidance midpoint, deliberately not above guidance). Previous FY2027 recurring net profit of RMB 9.0–11.5 billion adjusted to RMB 9.5–11.2 billion: lower bound raised on full-year consolidation of SMIC North and evidence of price hikes; upper bound lowered on peak depreciation expectations (possibly extending to 1H 2028).
Upcoming changes: Three verifiable marginal changes form the core of the opportunity — ① Earnings slope: Q3 gross margin guidance of 26–28% is another step up from Q2; SMIC North's 100% consolidation takes effect from Q3 (declining minority interest share + annualized accretion to attributable profit of roughly RMB 0.95–1.27 billion, based on the 2024 base); ② Binary policy: NDAA bicameral conference concludes Oct–Dec; stripping of MATCH provisions or passage into law would both trigger repricing; ③ Flows: whether southbound flows stabilize after sustained outflows (the single-day net buy of HKD 533 million on Oct 28 was immediately reversed by the largest single-day net sell of HKD 963 million on Oct 29; not yet confirmed).
Primary stock price driver: The degree of delivery of quarter-over-quarter gross margin expansion (price hikes × utilization of 93.7% (as disclosed, unverified) racing against depreciation +28–30%); leading indicators are the Q3 gross margin print on Nov 13, Q4 guidance, and 2027 contract price negotiations starting in December.
Verifiable expectation gap: The extreme divergence between the sell-side target price center (~HKD 96; investing.com aggregate mean 95.99, Oct 29) and the current price of HKD 44.96 (-53%) stems mainly from flow/rate/policy tail discounts rather than earnings downgrades; but this must be read both ways — most target prices were set in mid-August and have not been revisited after the selloff (coverage stagnation is indistinguishable from view maintenance), and reverse-engineered pricing shows the current price still embeds normalized earnings far above the current run rate. The direction of convergence depends on Q3/Q4 delivery and the NDAA outcome, not automatically upward.
Verification catalysts and falsification conditions: Verification — Q3 gross margin ≥27%, Q4 guidance no lower than 26%, 2027 long-term contract price increases materializing, southbound net buying for 5+ consecutive days; Falsification — Q3 gross margin below 26%, utilization falling below 88%, MATCH passed in a form covering maintenance of installed equipment, southbound weekly net selling exceeding HKD 2.0 billion.
On the facts: Q2's volume-and-price gains, utilization of 93.7% (93.1% in Q1; as disclosed, unverified), and Taiwan peers' cycle evidence were all verified against original announcements and multiple media sources. The company made no major negative announcements in Sep–Oct; the HKEX disclosure stream on Oct 12 contained only routine items such as monthly returns and share grant vesting. All three drivers of the decline can be located: the Fed's 25bp hike on Sep 16 (first since July 2023) accompanied by a hawkish dot plot; CICC's estimate that AI megacap (Mag7) capex growth decelerates from ~90% in 2026 to ~36% in 2027, sparking concerns over AI asset returns (Nasdaq -2% and SOX -2.7% on Oct 17; Hang Seng Tech -5.03% on Oct 22); and southbound funds' consecutive net selling of SMIC. But three weak signals must be placed alongside: Q3 revenue guidance was below then-prevailing sell-side expectations; part of the Q2 beat reflected customer pre-stocking (the Q3 QoQ slowdown to +2–4% may be a rebalancing); and UMC's Oct 28 announcement of an additional USD 3.2 billion in capex is both evidence of a strong cycle and a leading supply-side headwind for 2027–28. On the day of the late-October FOMC hold, southbound funds still net sold SMIC, indicating that "pure flow" attribution is also incomplete — the discount includes genuine pricing of earnings quality and cycle peaking.
Over the short window, PB 1.95x is the 1-year low percentile, a direct product of the -34% decline; over the long window, it remains at the 65th percentile over 5 years — "reversion to fair" and "not yet capitulated" coexist; directionally, this report judges it to be the lower bound of the fair range. Reverse-engineered pricing under two approaches: solving back from a mature foundry clearing PE of 17–24.5x, the H-share total market cap (~HKD 385.0 billion ≈ RMB 326.8 billion) implies normalized attributable profit of RMB 13.3–19.2 billion (RMB 19.9–28.6 billion under the same-currency market cap basis); PB-Gordon (g=3%) implies a steady-state ROE of 15.7–17.6% — both roughly 2x the FY2026E reality (ex-non-recurring RMB 7.0–7.8 billion, ROE ~5.8%). The scarcity and strategic premium has not fully cleared but has compressed substantially. Relative support comes from structure: the H shares trade at a ~62% discount to A shares (A/H = 2.65; A shares closed at RMB 101.00 on Oct 29 vs. H shares at RMB 38.17 equivalent; calculated in this report), a significantly cheaper entry point for the same asset; among peers, UMC trades at PB 3.08x (92nd percentile over 5 years), Hua Hong at 2.23x, and TSMC at 9.74x. The extreme sell-side target price dispersion of HKD 40–153 (Goldman Sachs 153 / UBS 96.2 / Daiwa 40) has seen no repricing from bulge-bracket banks in October despite the decline — this "center" is not used as a support anchor.
Of 2026H1 attributable net profit of RMB 4.467 billion (+94.2%), non-recurring items accounted for 33.0%; the ex-non-recurring RMB 2.994 billion (+57.2%) represents the true run rate. Operating cash flow of RMB 20.760 billion (+252%) includes RMB 4.29 billion of "deposits and others" inflows — excluding this, 1H free cash flow remains negative (approximately -RMB 3.26 billion under CAS; approximately -RMB 2.0 billion under IFRS). The "first FCF turnaround" relies on reversible items and does not constitute structural evidence. The genuine structural improvement lies in consolidation and investment cadence: SMIC North has been 100% consolidated since June 12 (annualized accretion to attributable profit of roughly RMB 0.95–1.27 billion based on a 2024 revenue base of RMB 12.98 billion, partially offset by 6.4% share dilution); but minority stakes in SMIC South (40.90%), SMIC Jingcheng (51.00%), and SMIC East (66.45%) remain high — the magnitude of the decline in minority interest share from Q3 is uncertain, and the Q3 report (Nov 13) is the first verification point. The biggest headwind is depreciation: 1H D&A of RMB 16.139 billion (+28.2%; Q2 IFRS basis +37.9%), company full-year depreciation of roughly +30%; the race between margin gains from price hikes and the depreciation ramp runs through 2027.
MATCH has been packaged into the Senate version, but its passage probability should be read at the low end: MATCH language has not entered any chamber-passed text (procedurally blocked twice in the Senate on July 14 and Sep 2); the historical base rate of "inserting" new sanctions provisions during bicameral conference toward the final text is low, and the FY2026 precedent moved in the deletion direction; the White House direction is also dovish (the AI advisor publicly pushed for removal of chip control provisions; BIS has not added new entity listings since October 2025). This report's subjective estimate: probability of core provisions becoming law is 15–25%, with a joint probability of ~0.15–0.20 for coverage extending to maintenance/spare parts of installed equipment. Impact quantification: if passed with maintenance coverage, PB could converge from 1.95x toward 1.2–1.4x (HKD 27.6–32.3, using calculated BVPS of 23.04), with an extreme tail of 0.9–1.0x (HKD 20.7–23.0, referencing the magnitude of the October 2022 sanctions panic); if only a weakened version passes, PB moves toward ~1.6x (HKD 36.5). The reverse branch (provisions stripped → geopolitical discount narrows) is directional inference, not a confirmed catalyst — during the intensive stripping-signal period of Jul–Sep, the stock fell rather than rose, indicating the discount mechanism operates through more than NDAA alone (direct BIS actions, NS-CMIC holdings restrictions, etc., are all at work).
Two hard supply-side constraints: ~70% of global 12-inch mature-node expansion in 2026 is in mainland China (TrendForce); company depreciation of roughly +30% in FY2026, with the peak possibly extending to 1H 2028 (Daiwa/CLSA basis). On sensitivity, a linear framework of ~-0.34pp gross margin per 1pp decline in utilization implies: a fall from 93.7% (as disclosed, unverified) to 85%/80% corresponds to gross margin of roughly -3.0/-4.7pp — but this framework ignores the price channel: from 2026Q1 to Q2, utilization rose only +0.6pp while gross margin rose +5.2pp; this cycle's gross margin swings are dominated by ASP and mix. The previous clearing cycle (FY2024 gross margin 18.6%) proved that ASP concessions amplify the shock when oversupply materializes. Under stress scenarios, FY2027 recurring attributable profit could fall from the base case of RMB 9.5–11.2 billion to RMB 4.5–6.0 billion (85% utilization) or even RMB 2.5–3.5 billion (80% plus price concessions). Evidence in the opposite direction is equally prominent: Powerchip guides mature-node prices to rise another 10–20% in 2027; UMC says 2027 price adjustments will be more significant in magnitude and coverage than 2H 2026; TSMC plans 3–10% price increases from 2027 — but all are negotiation targets or previews, and extrapolation across foundries to SMIC's standard-logic business warrants caution. The race between "price increases" and "volume supply" is the core 2027 debate; the observation window is 2026Q4 order visibility and 2027 long-term contract negotiations.
The marginal pricer of the H shares is southbound funds, while U.S. capital has been locked out since December 2020 under the NS-CMIC list and cannot step in (disclosed in the company's semi-annual report risk section), leaving the buy-side structure narrow. Southbound's sustained outflows were a direct driver of this selloff: net selling of ~HKD 1.41 billion over Oct 12–13, and cumulative net selling of ~HKD 4.6 billion over the 7 days to Oct 23; the single-day net buy of HKD 533 million on Oct 28 (rebound on volume) was reversed the next day by the largest single-day net sell of HKD 963 million on Oct 29 — no inflection point yet. The A/H ratio of 2.65 sits in a historically elevated zone (H at a 62% discount to A), reflecting both the depth of the H-share discount and the risk that an A-share catch-down would undermine the H-share pricing anchor. Next stress-test nodes: the December FOMC (UBS on Oct 15 projected one more hike each in December and March 2027; the latest pricing snapshot after the late-October hold was not obtained) and Mag7 capex guidance (late-January earnings season). Flow repair requires a confirmation signal on the order of "net buying for 5+ consecutive trading days."
Basis note: Except for the 2026Q2 column, which is on an IFRS USD basis, all figures are on an A-share CAS RMB basis; CAS and IFRS differ in areas such as fair value measurement, so all historical comparisons use a consistent basis.
| Metric | FY2023 | FY2024 | FY2025 | 2026H1 | 2026Q2 (IFRS) |
|---|---|---|---|---|---|
| Revenue | RMB 45.25bn | RMB 57.80bn (+27.7%) | RMB 67.32bn (+16.5%) | RMB 38.64bn (+19.4%) | USD 3.006bn (+36.1%, QoQ +20.0%) |
| Net profit attributable to parent | RMB 4.82bn | RMB 3.70bn (-23.3%) | RMB 5.04bn (+36.3%) | RMB 4.47bn (+94.2%) | USD 479mn (+261.7%) |
| Adjusted net profit (ex non-recurring) | RMB 3.27bn | RMB 2.65bn (-19.1%) | RMB 4.12bn (+55.9%) | RMB 2.99bn (+57.2%) | — (not disclosed under IFRS) |
| Gross margin | 21.9% | 18.6% | 21.6% | 22.9% (IFRS-derived) | 25.3% |
| Net margin | 10.7% | 6.4% | 7.5% | 11.6% | — |
| Operating cash flow | RMB 23.05bn | RMB 22.66bn | RMB 20.08bn | RMB 20.76bn (+252.0%) | — |
| Free cash flow (OCF − capex payments) | — | RMB -31.89bn | RMB -39.87bn | +RMB 1.04bn (approx. -RMB 3.26bn excluding deposits) | — |
| Cash + cash-like assets | — | — | — | RMB 94.47bn (as of 2026-06-30) | — |
| Interest-bearing debt | — | — | — | RMB 95.57bn (as of 2026-06-30) | USD 14.02bn |
| Debt-to-asset ratio | — | — | — | 33.8% | — |
| Net debt/EBITDA | — | — | — | ≈0 (net debt approx. -RMB 1.1bn) | — |
| Utilization (8-inch equivalent) | — | — | 93.5% full year | 93.4% | 93.7% (Q1 93.1%; per company announcement, unverified) |
| ASP (8-inch equivalent, RMB) | — | — | RMB 6,476/wafer (-2.5%) | RMB 6,667/wafer (+2.9%) | approx. USD 1,047/wafer (derived, +13.3%) |
| Monthly capacity (8-inch equivalent) | — | 947.6k wafers/month at year-end | 1,058.8k wafers/month at year-end | 1,096.5k wafers/month (Q2) | 1,096.5k wafers/month |
Reasons for metric changes (company explanations provided for YoY swings ≥ ±20%): ① Net profit attributable to parent +94.2% — company explanation: "higher wafer shipment volume, higher average selling price, and changes in product mix"; among this, fair value changes of associate funds of RMB 1.50bn were booked as non-recurring (company itself assesses this as unsustainable); ② Operating cash flow +252.0% — company explanation: "increase in cash received from sales of goods"; notes also show deposits and other inflows of RMB 4.29bn (prior period RMB 64mn, ~20.7% of OCF; if these are customer capacity-booking deposits, they corroborate demand, but the classification needs to be distinguished); ③ Short-term borrowings +320.6% from beginning of year to RMB 14.52bn — "increase in bank credit borrowings due within one year"; over the same period, minority shareholders contributed RMB 12.31bn in capital; ④ Cash +58.2% from beginning of year to RMB 69.05bn — "increase in sales collections and time deposits"; ⑤ Administrative expenses -38.2% — "reduction in start-up costs"; ⑥ FY2025 accounts receivable +111.0% (DSO rose from 18.5 to 33.4 days) — "adjustment of credit terms for certain customers"; ⑦ FY2025 non-operating expenses +2,236.9% — "recognition of litigation-related expenses" (arbitration award per PDF; the company has applied to set aside the award).
Q2 marked the second consecutive quarter of significantly beating the company's own guidance: revenue of USD 3.006bn, QoQ +20.0% (guidance was +14–16%), gross margin 25.3% (guidance 20–22%, a 3.3pp beat), utilization 93.7% (per announcement, unverified), a record for the period, and USD ASP of approx. USD 1,047/wafer, +13.3% YoY (derived in this report from announced revenue ÷ shipments). Net profit attributable to parent was USD 479mn (+261.7% YoY), of which fair value gains from associate funds contributed on the order of USD 230mn (H1 full-year basis: RMB 1.50bn). H1 overall: revenue of RMB 38.64bn (+19.4%), adjusted net profit RMB 2.99bn (+57.2%). Three structural highlights: ① shipments +14.9% in H1, faster than capacity growth, showing operating leverage from full utilization; ② after SMIC Northern was consolidated on June 12, minority-interest leakage still reached 34.6% of a single quarter in Q2 — a decline in this ratio from Q3 onward is the key validation point for net profit growth outpacing revenue growth; ③ H1 capex -19.6% YoY (RMB 19.73bn), running below the full-year guidance pace of "flat with 2025's USD 8.1bn" — if spending is not back-loaded in H2, full-year capex could come in below guidance, allowing the depreciation peak expectation to be pulled forward and moderated. On the risk side: Q3 revenue guidance of +2–4% QoQ was below the prevailing sell-side expectation (+7–9%), partly reflecting a rebalancing after Q2's forward stocking; depreciation +28.2% in H1 continues to cap gross margin elasticity. On market expectations: the FY2026 consensus net profit median was unavailable (no applicable consensus tool for H-share listings); this report anchors on management guidance and its own extrapolation, and does not make quantitative "beat/miss" judgments against the market.
Business model: Asset-heavy foundry platform (manufacturing type), with 12-inch revenue at 77.4% of the mix and a specialty-process focus (consumer electronics at 45.1% of revenue; industrial & automotive at 15.4% and rising rapidly); revenue is non-subscription-based and fluctuates with utilization and capacity cycles; pricing power is cyclical price increases (negotiated hikes for supply-constrained categories), not structural pricing power — FY2025 ASP -2.5% turning to +2.9% in 2026H1 is a footnote to this cyclical nature.
Cash content of earnings: OCF/net profit attributable for FY2023–2025 was 4.78 / 6.13 / 3.98, and 4.65 in 2026H1 (approx. 3.7 excluding deposits) — book profits are almost fully covered by cash flow supported by large depreciation; the cash content itself is not poor. The problem lies in free cash flow: FCF was RMB -31.89bn in FY2024 and RMB -39.87bn in FY2025, deeply negative for two consecutive years and plugged by minority shareholder capital injections and borrowings; 2026H1 turned positive (+RMB 1.04bn) but remains approx. -RMB 3.26bn after excluding RMB 4.29bn of reversible deposits. Recurring earnings test: the H1 gap between attributable and adjusted profit was 33.0% (≥15% threshold), with RMB 1.50bn from associate fund fair value (Level 3 valuation, highly correlated with AI asset prices); core profit was actually RMB 2.99bn, trending upward. Reverse test on the company's own reporting: the company does not disclose a Non-GAAP profit measure; adjusted profit is audited-basis with no aggressive add-backs — clean on this point.
Return on capital: ROIC approx. 2.9% (FY2025; NOPAT ≈ net profit + after-tax interest / invested capital of RMB 335.0bn) — significantly below the cost of capital for asset-heavy semiconductor manufacturing (WACC approx. 9–9.5%); pre-depreciation returns are high (EBITDA margin 56.1%) but depreciation consumes profits, a typical pattern of "ROIC artificially depressed during an asset-heavy expansion phase"; ROIC will improve as earnings rise in 2026 but is unlikely to exceed WACC before the depreciation peak in 2027.
Capex quality: Capex/depreciation was 2.36 in FY2024, 2.20 in FY2025, falling to 1.22 in 2026H1; the company does not split maintenance vs. growth capex. H1 saw RMB 38.63bn of assets placed into service (expansions in Shanghai/Beijing/Tianjin/Shenzhen, 95–98% complete) and construction-in-progress of RMB 69.89bn (-24.5% vs. year-end) — investment is shifting from the construction phase to the capacity-ramp payback phase, a healthy direction; capacity grew from 947.6k wafers/month at FY2024 year-end to 1,096.5k wafers/month in 2026Q2 (8-inch equivalent).
Red flags: ① Non-recurring items as % of attributable profit were 32.2%/28.5%/18.2%/33.0% for FY2023–2026H1, persistently above 15%; ② deeply negative FCF + continuous external financing (minority capital injection of RMB 12.31bn in H1 + short-term borrowings +320.6%); ③ declining but still present reliance on government subsidies (subsidies as % of total profit within other income: FY2024 45.3% → FY2025 43.1% → 2026H1 14.7%; deferred subsidy balance steadily drawn down from 4.12 → 3.99 → 3.55bn RMB); ④ no dividends, no buybacks — zero cash return to shareholders during the asset-heavy expansion phase.
Consistency of words and deeds: pragmatic, leaning conservative. Guidance vs. actuals over the last four quarters: 2025Q3 guided Q4 revenue flat to +2% QoQ (actual +4.5%), gross margin 18–20% (actual 19.2%) — delivered; 2025Q4 flash guidance for 2026Q1 revenue flat QoQ (actual +0.7%), gross margin 18–20% (actual 20.1%) — delivered; 2026Q1 guided Q2 revenue +14–16% QoQ (actual +20.0%), gross margin 20–22% (actual 25.3%) — substantially beaten; FY2024 annual report pledged "2025 revenue growth above comparable peers, capex flat" — revenue +16.2% delivered, capex USD 8.10bn slightly above the flat target. Two consecutive quarters of large beats suggest guidance is set conservatively — a "pragmatic" type.
Shareholder friendliness: neutral-to-negative (expansion first). FY2025 proposed no distribution, no interim dividend, no buybacks during the period — zero cash return to shareholders; in 2026H1, 547mn A-shares were issued (at RMB 74.20/share) to acquire 49% of SMIC Northern (approx. 6.4% dilution), plus additional shares from H-share incentive vesting. Trading dilution for assets (Northern consolidation adds to attributable profit) is not strictly P&L-neutral for shareholders, but the combination of zero dividends + ongoing dilution is acceptable during an earnings upcycle and would be re-examined in a downturn.
Risk signals: Related-party transactions are small (H1 sales to Datang Holdings of RMB 78.56mn, far below the annual cap); all 4 responses on the investor interaction platform in the past 120 days were procedural shareholder-count replies — management has not publicly addressed substantive issues such as pricing sustainability or the declining US-region revenue share (FY2025 11.6% → 2026H1 8.7%) — some reticence on transparency.
| Dimension | Segment | Revenue share | Gross margin | YoY/trend | One-line business logic |
|---|---|---|---|---|---|
| Product | Wafer foundry | 94.3% (of main business, FY2025) | 21.3% (FY2025); approx. 22.8% in 2026H1 | FY2025 +17.9% | Specialty-process foundry; prices fluctuate with utilization and capacity cycles |
| Product | Others (photomasks/design services/IP) | 5.7% | 32.0% | -2.0% | One-stop support; high margin but small scale |
| Region | China | 89.6% (2026H1) | Not disclosed | +4.0pp vs. FY2025 | Driven by onshoring reshoring and domestic substitution |
| Region | US | 8.7% (2026H1) | Not disclosed | -2.9pp | Persistently shrinking share; lower geopolitical exposure |
| Application | Consumer electronics | 45.1% (2026H1) | Not disclosed | Share rising | Low-end SoC/CIS/drivers; value-for-money competition |
| Application | Industrial & automotive | 15.4% (2026H1) | Not disclosed | +5.3pp YoY, fastest | Automotive qualification + second curve of domestic substitution |
| Wafer size | 12-inch | 77.4% (2026H1) | Not disclosed | Steady upward | Main battlefield of expansion (Shanghai/Beijing assets placed into service) |
Unsurprisingly, the profit engine is the core wafer foundry business (94.3% of revenue); the "Others" segment's 32.0% gross margin is 10.7pp above the core business (≥10pp must be flagged) — photomasks and design services are asset-light support businesses with better bargaining power than manufacturing, but their scale is insufficient to change the group's earnings structure. By region, the growth engine has shifted to China (89.6%) + industrial & automotive applications: a direct reflection of domestic substitution and spillover from the AI power chain; the shrinking US region is both a consequence of export controls and a reduction in geopolitical exposure of overseas revenue.
Accounting red flags: ① Associate fund fair value gains inflating profits (high) — 33% of H1 attributable profit; underlying assets at Level 3 valuation, company itself assesses as unsustainable; ② operating cash flow amplified by deposit inflows (medium) — RMB 4.29bn of current-account receipts are reversible, 20.7% of OCF, appearing concurrently with the surge in short-term borrowings; ③ short-term borrowings +RMB 11.07bn in half a year (medium) — combined with RMB 94.47bn of cash-like assets, this forms a "high deposits, high borrowings" structure whose interest-spread motive warrants tracking; ④ FY2025 accounts receivable +111%, far above revenue +16.5% (medium) — DSO rose 18.5 → 33.4 days; company attributes it to credit term adjustments; no further deterioration by H1-end; ⑤ FY2025 inventory volume +36.8% exceeding shipments +20.9% (low) — production stockpiling; if demand weakens, impairment risk amplifies (RMB 153mn already provisioned in H1).
Cross-period consistency: ① OCF declined for three consecutive years (23.05 → 22.66 → 20.08bn RMB) then surged 2.5x in H1 — no reason line was attached to the FY2025 decline (unexplained); H1 explained as sales collections (coexisting with deposit inflows; classification needs distinguishing); ② DSO jump then holding steady — consistent with the company's explanation; ③ government subsidy cash receipts declining 3.53 → 2.54 → 0.28bn RMB with deferred balances steadily drawn down — unexplained by the company; the trend indicates subsidy reliance is fading; ④ minority interest share of net profit at a high 30.1% → 30.6% — consistent with the equity structure before SMIC Northern's consolidation; the structure changes from H2. Overall: no hard evidence of fabricated revenue or profits; the main issue is "selective classification between profits and cash flows" — fair value and deposits are two items that warrant a discount to the quality of headline numbers.
Current market data (2026-10-29 close): H shares at HK$44.96; total share capital 8.562 billion shares (6.015 billion H + 2.548 billion A, monthly report as of 2026-09-30); market cap on H-share full share count basis: HK$385.0 billion (≈US$49.07 billion); split-currency basis (H × 44.96 + A × RMB 101.00) ≈ HK$573.5 billion equivalent. PB 1.95x (BVPS HK$23.04 = IFRS equity attributable to parent US$25.149 billion as of 2026-06-30 ÷ 8.562 billion shares × 7.8452, independently calculated in this report); at the 0th percentile over the past 1 year, 41% over 3 years, 65% over 5 years, 77% over 10 years; PE(TTM) 47.2x (1-year low; 59th percentile over 5 years) — earnings are in an upcycle, heavy depreciation investment phase, and TTM includes ~RMB 1.8 billion in one-off gains, so PE percentile is for reference only and not a headline; PS(TTM) 4.44x, about 35% below Hua Hong's ~6.79x. Forward basis: FY2026E attributable net profit midpoint of RMB 9.4 billion corresponds to ~34.8x; FY2027E midpoint of RMB 10.3 billion corresponds to ~31.7x; PEG is distorted at both ends by depreciation-distorted base (FY2026E growth +86% vs FY2027E +9.6%), used only for cross-validation. FX: HKD/CNY 0.848915, USD/CNY 6.6611 (spot, 2026-10-29).
| Peer | PE | PB | Gross Margin | Growth | Notes |
|---|---|---|---|---|---|
| SMIC H | 47.2x (TTM) | 1.95x | 25.3% (Q2) | Q2 +36.1% | PB at 65th percentile of 5 years; H-to-A premium 62% |
| TSMC | 28.0x | 9.74x | 66.4% (Q3) | Q3 +41.2% | Advanced-node monopoly, not direct competition |
| UMC | 17.1x (~24.5x adjusted) | 3.08x | 34.0% (Q3) | Q3 +25.6% | Mature + specialty, gross margin 9pp higher |
| Hua Hong Semiconductor | Distorted, excluded | 2.23x | 16.5% (Q2) | Q2 +26.8% | No. 2 in mainland China, utilization 102.8% |
| PSMC | 33.9x | 4.67x | N/A | Q2 QoQ +13.8% | Beneficiary of 8-inch PMIC price hikes |
Market-implied expectations: Back-solving from a mature foundry clearing PE of 17–24.5x, the current price implies normalized attributable net profit of RMB 13.3–19.2 billion (RMB 19.9–28.6 billion on the split-currency basis) — roughly 2x FY2026E ex-one-offs (RMB 7.0–7.8 billion); PB-Gordon (g=3%) back-solve implies steady-state ROE of 15.7–17.6%, versus a realistic FY2026E of ~5.8% and ~7.5% in the bull case for FY2027E. In one sentence: the current price requires SMIC to grow earnings to ~1.4–2x the current run rate by 2027–28 — achievable only on the bull path; the scarcity premium has not fully cleared but has compressed sharply versus early September.
Three-layer value (EPV): Asset value HK$23.04/share (IFRS BVPS, conservative proxy for replacement cost); EPV with zero growth HK$27.74/share (normalized FCFF HK$2.65/share ÷ WACC 9.5%, bridged by net debt of ~HK$0.15/share; normalized basis = current run rate of 1,096.5k wafers/month capacity, 93.7% utilization (per company announcement, unverified), and Q3 guidance gross margin of 26–28%, with FY2027 growth excluded from the base period; sensitivity range HK$22.9–31.9) — about 62% of the current price is supported by zero-growth cash flow; the residual ~HK$17.2 (about 38% of the current price) is the growth premium for continued price-hike cycle + advanced-node optionality + scarcity as mainland China's only 7nm volume producer. Asset floor of HK$23.04 (-48.7% vs current price) serves as an independent reference.
Three scenarios and odds (probabilities assigned by this report):
| Scenario | Probability | Fair Range | vs Current | Core Assumptions |
|---|---|---|---|---|
| Bear | 25% | HK$27–36 | Midpoint 31.5, ~-30% | MATCH Act covers existing maintenance (joint probability 0.15–0.20, PB 1.2–1.4x = 27.6–32.3) or 2027 oversupply + depreciation peak + second capital shock (PB 1.4–1.6x ≈ 33–37); extreme tail PB 0.9–1.0x = 20.7–23.0 |
| Base | 50% | HK$46–51 | Midpoint 48.5, ~+7.9% | Q3 gross margin 26–28% delivered, Q4 27–29%; FY2026 attributable net profit RMB 8.8–10.0 billion; FY2027 revenue +12–17%, gross margin 28–30%, attributable net profit RMB 9.5–11.2 billion (NAURA full-year consolidation vs depreciation +15–20%); exit PB 1.9–2.1x × BVPS'27E 24.3 (anchors: Hua Hong current 2.23x × 0.85–0.95, UMC 3.08x with 30–40% discount, own 3-year median 2.25x with 10–15% discount; independent of the company's current multiple) |
| Bull | 25% | HK$57–62 | Midpoint 59.5, ~+32% | Third round of price hikes extends through 2027 + AI power chain / advanced logic spillover exceeds expectations (advanced capacity path of 98k wafers/month by 2028); FY2027 attributable net profit RMB 12.5–14.0 billion; PB 2.3–2.5x × BVPS'27E 24.7 (2021 high zone, still below the 3.3x lower bound implied by the most bullish sell-side target) |
Probability-weighted fair value ~HK$47.0 (+4.5% vs current price); the current price sits below the lower bound of the base scenario, in the lower part of the bear-bull distribution — odds are near symmetric, slightly positive; margin of safety +2.3% (on the base-case fair lower bound of HK$46) is thin but not negative. Sell-side bookends: most bearish Daiwa at HK$40 (1.1x average 2026–27E PB) sits above this report's bear-case upper bound — this report's bear case is more conservative, as it places the MATCH Act extreme tail (HK$20.7–23.0) in the left tail of the distribution; most bullish Goldman Sachs at HK$153 was set in a HK$60–80 range and not re-rated after the -34% decline, so not adopted.
Conclusion: Fair. Assess fundamentals (undisputed mainland foundry leader, 93.7% utilization, true cash earning power on an FCFF basis better than the depreciation-depressed net profit) separately from price (PB at a 1-year low but still implying double the realistic normalized earnings) — a good company, price has reverted to the lower bound of fair, no thick margin of safety. Rationale for the base-case exit multiple of PB 1.9–2.1x: Hua Hong's current 2.23x at an 85–95% haircut (scale and product-mix disadvantage), UMC's 3.08x with a 30–40% discount (geopolitical and liquidity discount for mainland capacity), own 3-year median of 2.25x with a 10–15% discount (rising rate environment); three independent anchors converge on the same range.
Industry size: Global wafer foundry expected to reach US$218.8 billion in 2026, +24.8% YoY (TrendForce, 2026-03-19); pure-play foundry basis ~US$165 billion in 2025, +17% YoY (Counterpoint, 2026-02), a 4-year CAGR of ~12% from US$105 billion in 2021. Structural divergence: 7nm-and-below advanced nodes account for over 56% of 2025 revenue; mature nodes (≥28nm) share has fallen to ~36% (54% in 2021), corresponding to ~US$59.4 billion. Mature-node revenue is "broadly flat," with only 28nm maintaining ~5% CAGR (Counterpoint); 2026–27 growth is mainly price-driven — 8-inch utilization ~80% in 2025 → 88% in 2026, ~90% in H2, with industry-wide price hikes extending into 2027 (TrendForce, 2026-06-30). In 2026Q2, the global Top 10 foundries posted revenue of US$53.49 billion, +11.5% QoQ, setting consecutive historical highs (TrendForce, 2026-09-09). Total semiconductor market: WSTS forecasts 2026 +26% to US$975.5 billion.
Quantified chain of the demand inflection (AI spillover): The upstream driver of this mature-node shortage is the spillover from AI compute buildout — AI servers/general servers drive surging demand for power management ICs (PMICs), power discrete devices, and high-voltage BCD (industry estimates: a 72-GPU AI rack uses ~16,000 PMICs; single secondary source, magnitude reference only), compounded by the memory supercycle crowding out capacity (server DRAM 3Q26 contract prices +13–18% QoQ), shifting orders from Taiwan/Korea to mainland foundries. Transmission has been quantified: 8-inch foundry prices up 5–15% across the board 1Q26→2Q26; 12-inch mature hot nodes up 5–10% 2Q26→3Q26; a third round of hikes under negotiation; TSMC's July 2026 earnings call explicitly limited mature-node expansion and plans a 3–10% overall price increase from 2027 (base 5–10%); Samsung raised mature-node prices 10–20% while cutting output; global 8-inch capacity posts negative growth through H1 2027. SMIC's position to capture this: China-region revenue at 90.2% (2Q26); industrial and automotive revenue share rose from 10.6% to 16.5% (2Q26); management stated in investor research that "a large number of overseas customers have shifted orders to mainland China manufacturing, and we expect significant reshoring of production demand for mobile phones, computers, IoT, and networking products for at least the next two years" (May 2026 research notes). Precise quantification of company-level share gains via the "shipments × per-rack usage" chain still lacks first-hand data and remains qualitative pending quantification.
Value chain and value distribution: Upstream — semiconductor equipment is the most critical bottleneck: lithography (ASML DUV; EUV unavailable to mainland China, NXT:2000i and above require Dutch licenses), etch/thin film (AMAT/Lam/KLA/TEL), EDA (Synopsys/Cadence/Siemens together hold 70–80% of the China market; a one-month supply suspension in May 2025 was lifted); upstream holds strong bargaining power over mainland foundries and access is politically constrained (SMIC must prepay to lock in equipment). Midstream — foundry manufacturing: capital-intensive (a single 12-inch fab requires US$8–10 billion), depreciation-dominated cost structure; the bulk of gross profit stays in advanced nodes (TSMC 66.4% vs UMC 34.0%, SMIC 25.3%, Hua Hong 16.5%). Downstream — Fabless design houses are highly fragmented; foundry competition is intense in normal years; under 2026 supply shortage, bargaining power has reversed (fabs issued price-hike letters, customers can only negotiate timing). SMIC is weak versus upstream (export controls + seller monopoly), fluctuates with the utilization cycle versus downstream, and is currently in a strong position.
Supply-demand and competitive landscape: Extremely high concentration — 2Q26 Top 10 accounted for ~96% of the global total (TrendForce); shares: TSMC 72.5%, Samsung 5.9%, SMIC 5.4% (third), UMC 3.9%, GlobalFoundries 3.2%, Hua Hong ~2.4%. On Counterpoint's basis, SMIC's share rose from 5.1% to 5.4% in 2Q26, with revenue +36% YoY as the main driver beyond TSMC, narrowing the gap with Samsung to ~0.5pp — the "single-quarter global No. 2" narrative milestone is in sight (the two bases align: both TrendForce and Counterpoint put SMIC's share at ~5.4%, with small methodological differences). Entry barriers: capital (US$8–10 billion per fab), accumulated process yield expertise, equipment access (EUV banned, DUV progressively tightened), customer qualification cycles (automotive-grade 2–3 years). Competitive dynamics: after the 2023–25 mature-node price war, 2026 turned into a price-hike cycle; the 2027–28 risk lies in concentrated release of new mainland capacity (mainland drove ~70% of global 12-inch mature-node expansion in 2026; TrendForce long-term basis: mainland 12-inch CAGR 18.8% (2021–2030), mainland share of global mature capacity 22% (2021) → 49% (2030E) — milder than the "27% CAGR" old narrative circulating in early 2025, direction unchanged).
Cycle and regulation: Semiconductors are in an AI-driven super upcycle (WSTS: 2025 +22%, 2026E +26%), but in October 2026 capital markets corrected sharply on concerns about the sustainability of AI capex (stock prices diverging from fundamentals — SMIC's -34% in this round occurred against this backdrop). Leading indicators: 8-inch utilization (80% → 88% → 90%), company utilization (SMIC 93.7% (announced, unverified), Hua Hong 102.8%, UMC 2Q 85% → Q3 guidance >90%), pricing rounds (three rounds of hikes), order visibility (SMIC Q4 orders locked in), memory contract prices. Regulation: US entity list since December 2020, progressively tighter Dutch DUV controls, the MATCH Act potentially extending to repair services with statutory listing (see C4 for details); the EDA supply suspension was lifted within a month, showing back-and-forth in enforcement; support from China's Big Fund system (Phase III direct investment of US$1.832 billion in SMIC South).
Company positioning: Global mature-node head player and absolute mainland leader — global No. 3 (5.4%, closely trailing Samsung), mainland China revenue share 90.2%, monthly capacity of 1,096.5k wafers (8-inch equivalent) — the largest in mainland China. Share trend is upward (revenue more than doubled over four years, consistently ranked third); moat stems from: the largest 12-inch mature capacity in mainland China with localized manufacturing positioning, full-category mature + specialty platforms, and the inherent scarcity of geopolitical barriers for mainland customers. Advanced nodes (N+1/N+2-class 7nm-level) cannot achieve commercial volume under equipment controls — an option, not current earnings.
The generic financial framework for wafer foundry misses four marginal variables that determine quarterly results; listed separately here:
Overall assessment: Cautiously bullish, confidence 0.55, horizon 12 months. SMIC's fundamental momentum (volume and price both rising, full utilization, consolidation accretion, first-hand evidence of the price-hike cycle extending into 2027) and the H-share price (PB 1.95x, lowest 1-year percentile, 2.3% discount to the base-case fair lower bound) have realigned after the -34% panic clearing. Expected return ~+4.5% (probability-weighted), +7.9% to the base-case midpoint, -30% to the bear-case midpoint, +32% to the bull-case midpoint — odds are symmetric and slightly positive, with no thick margin of safety. Strategically, the current price suits building positions in stages rather than heavy concentration: the upside requires at least two of Q3/Q4 delivery + NDAA clause removal + southbound stabilization to be confirmed; downside protection relies on valuation floors (asset value HK$23.04, EPV HK$27.74) rather than an earnings safety cushion.
Risk and catalyst calendar:
Falsification conditions (reassess upon trigger): Q3 gross margin below 26% or revenue turning negative QoQ; quarterly utilization falling below 88%; MATCH Act enacted covering existing equipment maintenance; JV fair value turning negative in a single quarter by more than RMB 1 billion, or the ex-one-offs/attributable scissors gap widening beyond 60%; southbound weekly net selling exceeding HK$2 billion with the AH ratio rising above 3.0. Upside catalysts: Q3 gross margin ≥27% with Q4 guidance no lower than 26%; 2027 long-term contract price hikes landing; SMIC South's US$7.778 billion capital increase paid in within the year (contractually required no later than 2026-12-31); southbound net buying for 5 or more consecutive days.
Data in this report are as of the 2026-10-29 close. Prices and multiples are anchored to that date; the latest financial statements are the 2026 semi-annual report (2026-08-27) and the 2026Q2 results announcement (2026-08-13). This report is generated by Loyan AI and does not constitute investment advice.